Investigating wet cupping therapy's effect on brain oxygen levels
Investigation of Wet Cupping Therapy Effect on Cerebral Oxygenation Levels by NIRS
NA · Karabuk University · NCT06540781
This study is testing whether wet cupping therapy can improve oxygen levels in the brain for healthy adults aged 18-65.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Karabuk University (other) |
| Locations | 1 site (Kayseri) |
| Trial ID | NCT06540781 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of wet cupping therapy (WCT) in improving cerebral oxygenation using a near-infrared spectroscopy (NIRS) device. Healthy participants aged 18-65 will undergo a single session of WCT, during which their cerebral oxygen levels will be monitored before, during, and after the treatment. The study will measure changes in regional cerebral oxygen saturation (rScO2) to determine the impact of WCT on brain oxygen levels. The findings could inform future applications of WCT in stroke rehabilitation.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy individuals aged 18 to 65 who consent to participate.
Not a fit: Patients with contraindications for wet cupping therapy or those with chronic conditions and on medication may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a novel therapeutic approach to enhance cerebral oxygenation, potentially benefiting stroke rehabilitation.
How similar studies have performed: While the use of wet cupping therapy is traditional, this specific application using NIRS to measure cerebral oxygenation is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy individual * Age 18-65 years * Consent to participate Exclusion Criteria: * Having received cupping therapy in the past 3 months * Contraindications for WCT (such as hemoglobin level below 9.5 g/dL, bleeding disorders, receiving antithrombotic or antiplatelet therapy, INR value above 1.5), * Coexisting chronic conditions and using any medication
Where this trial is running
Kayseri
- Kayseri City Hospital — Kayseri, Turkey (RECRUITING)
Study contacts
- Study coordinator: Suleyman Ersoy
- Email: suleymanersoy@gmail.com
- Phone: 05052628001
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cerebral Hypoxia, Cerebral oxygenation, Wet cupping therapy, NIRS